ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 155 filers reported holding ANTARES PHARMA INC in Q1 2020. The put-call ratio across all filers is 347.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,411,000 | +57.3% | 344,200 | +37.0% | 0.28% | +72.6% |
| Q4 2021 | $897,000 | +9.1% | 251,200 | +11.2% | 0.16% | -3.5% |
| Q3 2021 | $822,000 | -6.1% | 225,900 | +12.6% | 0.17% | -11.5% |
| Q2 2021 | $875,000 | +6.2% | 200,600 | 0.0% | 0.19% | +13.6% |
| Q1 2021 | $824,000 | +3.0% | 200,600 | 0.0% | 0.17% | -19.9% |
| Q4 2020 | $800,000 | +47.6% | 200,600 | 0.0% | 0.21% | +15.9% |
| Q3 2020 | $542,000 | -1.8% | 200,600 | 0.0% | 0.18% | -16.1% |
| Q2 2020 | $552,000 | +16.7% | 200,600 | 0.0% | 0.22% | -16.9% |
| Q1 2020 | $473,000 | -10.4% | 200,600 | +78.6% | 0.26% | +48.3% |
| Q4 2019 | $528,000 | – | 112,300 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |